Trials / Sponsors / Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Academic / Other · 6 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | Adaptive Neoadjuvant Therapy for Esophageal Cancer Esophageal Carcinoma, Neoadjuvant Therapy | N/A | 2028-03-01 |
| Not Yet Recruiting | Exploratory Clinical Study of Personalized mRNA Tumor Vaccine RH125 in Patients With Advanced Solid Tumors Solid Tumor Malignancies | EARLY_Phase 1 | 2025-09-15 |
| Recruiting | A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Thi Pancreatic Cancer Metastatic | Phase 1 / Phase 2 | 2025-05-26 |
| Recruiting | A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer Gastric Cancer | Phase 1 / Phase 2 | 2024-08-03 |
| Recruiting | Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advan Metastatic Colorectal Cancer | Phase 1 / Phase 2 | 2023-12-25 |
| Completed | Surgical Resection Enhances Survival in Gastric-type Endocervical Adenocarcinoma: A SEER-Based Study Gastric-type Endocervical Adenocarcinoma | — | 2000-01-01 |